ask="17.7000"
ask_size="41000"
average_daily_volume="24723"
bid="2.7100"
bid_size="1000"
book_value="-0.2280"
change="+0.0499"
change_from_200_day_moving_average="-0.8387"
change_from_50_day_moving_average="0.1127"
change_from_52_week_high="-2.6801"
change_From_52_week_low="1.0060"
change_in_percent="+1.8080%"
close="2.8099"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.6700"
ebitda="-49.36M"
eps_estimate_current_year="-2.2500"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-2.5000"
ex_dividend_date="N/A"
float_shares="9614000"
high="2.9400"
high_52_weeks="5.4900"
last_trade_date="1/20/2017"
last_trade_price="2.8099"
last_trade_size="100"
last_trade_time="3:57pm"
low="2.7600"
low_52_weeks="1.8039"
market_capitalization="66.25M"
moving_average_200_day="3.6486"
moving_average_50_day="2.6972"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.0000"
open="2.9400"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-22.9877%"
percent_change_from_50_day_moving_average="+4.1769%"
percent_change_from_52_week_high="-48.8178%"
percent_change_from_52_week_low="+55.7681%"
previous_close="2.7600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="21.8405"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="0.1900"
stock_exchange="NGM"
symbol="ONS"
volume="20961"
weeks_range_52="1.8039 - 5.4900"
